SaaS Platform Riffyn Secures $15 Million Series B Funding to Advance Big Data Solutions for Medical R&D

2019Year5Month29Day, VCBeat (WeChat Official Account:vcbeat) learned，Cloud Computing Software and Data Analytics CompanyRiffynAnnounced Completion1500$10,000B-round financing, with this round of investment led byM VenturesLead Investor,Waters Corporation、O'Reilly AlphaTech VenturesandPlug and Play VenturesCo-investment.

It is understood that the company will use the funds raised to expand global sales and scientific and technological services, and will accelerateRiffynthe process development and advanced data analytics technology development progress.

Prior to this,RiffynCompleted3round of financing, raising a total of9900ten thousand U.S. dollars. Major investors includeBioeconomy Capitaland Oreilly Alpha Tech Venturesetc.

Riffynis a company that develops cloud computing software and provides assisted process design and advanced data analytics for computers.RiffynCapable of providing robust, high-quality data services for product development. Riffyn can provide robust, high-quality data services for product development, with the mission of delivering clean, connected, and meaningful data for scientific research and development. The company was founded in2014The founding team consists of veterans from the life sciences and high-performance computing industries, with its headquarters currently located in Oakland, California.

RiffynReal-time integration of heterogeneous scientific data technologies can support machine learning and artificial intelligence. Its unique adaptive technology enables scientists to continuously improve the R&D process while seamlessly integrating relevant experimental data. In the front15Among major biotechnology and pharmaceutical companies, there are8All useRiffynThe provided technology enables reproducible scientific research, accelerates product development, and ensures accurate initial technical scale-up.

“We are deeply honoredM VenturesandWaters CanBecomeRiffyninvestors and directors.”RiffynFounder and CEOTim Gardnersaid, “They bring a wealth of experience and expertise to the life sciences market, which will provide new momentum for our already rapidly growing market.” 

M Venturesis located in Darmstadt, GermanyMerck KGaAThe company's strategic venture capital division.M VenturesFocused on early-stage investment andInnovative Enterprise Incubation, and is committed toEnable Emerging Technology Companies to Achieve Commercial Success。

WatersCompany (New York Stock ExchangeStock Code：WAT), a world-leading professional measurement company,60For many years, it has been dedicated to providing chromatography, mass spectrometry, and thermal analysis, along with technological innovation, for the life, materials, and food sciences. And in100Products are available in multiple countries and regions.WatersGlobally, with15Manufacturing Plant and Agreement7000named employees, in31countries and to100Products are available in multiple countries and regions.

(Compiled by Wu Yucheng)